GN

Gajanan Nanaji Regundwar

Active Director Director DIN 07087818
DIN 07087818 First appointment Mar 2015 Primary industry Life Sciences
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Gajanan Nanaji Regundwar

Data last updated:

Gajanan Nanaji Regundwar is a Director at Mansoon Biotech Private Limited (since 2015). The company operates in Life Sciences.

DIN 07087818
Primary Designation Director
Industry Life Sciences
First Appointment 03 Mar 2015
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mansoon Biotech Private Limited U74999MH2015PTC262362
Director03 Mar 20152015Active

Board colleagues of Gajanan Nanaji Regundwar

NameDINCompanyDesignation
Amit Gajanan Regundwar07087812Mansoon Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mansoon Biotech Private Limited
Premium access

Shareholding and investment profile for Gajanan Nanaji Regundwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gajanan Nanaji Regundwar

Gajanan Nanaji Regundwar currently holds 1 directorship: Mansoon Biotech Private Limited (Director, since 03 Mar 2015).

Gajanan Nanaji Regundwar was first appointed on 03 Mar 2015 as Director at Mansoon Biotech Private Limited.

The current boards of Gajanan Nanaji Regundwar's companies include Amit Gajanan Regundwar (Mansoon Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available